Get my own profile
Public access
View all18 articles
1 article
available
not available
Based on funding mandates
Co-authors
Nicholas P Restifo, MDCellular Immunotherapy ExplorerVerified email at medici.co
Robert EilOregon Health & Science UniversityVerified email at ohsu.edu
Christopher A. Klebanoff, M.D.Associate Member, Memorial Sloan Kettering Cancer CenterVerified email at mskcc.org
Rahul RoychoudhuriUniversity of CambridgeVerified email at cam.ac.uk
Gautam MehtaFDA OncologyVerified email at fda.hhs.gov
Luca GattinoniLeibniz Institute for Immunotherapy (LIT)Verified email at lit.eu
Neville SanjanaCore Faculty, New York Genome Center. Associate Professor, NYU.Verified email at nyu.edu
toren finkelUniversity of PittsburghVerified email at pitt.edu
Klaus OkkenhaugDivision of Immunology, Department of Pathology, University of CambridgeVerified email at cam.ac.uk
Eric TranEarle A. Chiles Research Institute, Providence Cancer CenterVerified email at providence.org
J. Silvio Gutkind, Ph.D.UCSD, Distinguished Professor and Chair, Dept. Pharmacology, AD Basic Science Moores Cancer CenterVerified email at ucsd.edu
Warren J. LeonardChief, Laboratory of Molecular Immunology and Director, Immunology Center, National Heart, Lung, andVerified email at helix.nih.gov
Mahadev RaoManipal Academy of Higher EducationVerified email at manipal.edu
suman mitraPrincipal investigator, Univ. Lille, CANTHER, CNRS 9020, INSERM UMR 1277, CHU Lille,Verified email at inserm.fr
CAstraZeneca